硫酸乳古 (SLA) 考古体作为疫苗辅助剂
Bassel Akache1, Michael J McCluskie1
1Department of Immunobiology, National Research Council Canada, Human Health Therapeutics, Ottawa, Ontario, Canada.
Human vaccines & immunotherapeutics
|September 15, 2024
概括
硫酸乳酪氨基醇 (SLA) 考古体是一种新型的疫苗辅助剂. 在临床前研究中,这些脂质体增强了免疫反应,并对传染病和癌症进行了保护.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 脂质纳米技术 脂质纳米技术
背景情况:
- 考古酶体是从以太结合的异oprenoid 脂质中衍生出来的脂质体.
- 传统的古生物体使用总极性脂质或半合成糖脂质.
- 半合成的古生物体为免疫学应用提供了可调节的特性.
研究的目的:
- 审查 sulfated lactosylarchaeol (SLA) 考古体作为疫苗辅助剂的开发和应用.
- 突出SLA骨基因组在增强免疫反应方面的潜力.
- 讨论它们在传染病和癌症的临床前模型中的有效性.
主要方法:
- 使用SLA.开发了一种半合成的古细胞体配方.
- 系统免疫接种后评价幽默和细胞介导免疫力.
- 在临床前模型中测试各种抗原,包括病毒和癌症抗原.
主要成果:
- SLA 考古酶很容易合成和配制.
- 它们诱导强大的幽默和细胞介导免疫反应.
- 在C型肝炎,B型肝炎,流感,RHDV和SARS-CoV-2的模型中证明了增强的保护.
结论:
- SLA 骨基因组代表了一个安全有效的疫苗辅助剂平台.
- 它们的多功能性支持对各种传染病和癌症的应用.
- 随着COVID-19的爆发,人们越来越需要先进的辅助技术,比如SLA的古基因组.
关键词:
在SLA中,SLA就是SLA.疫苗 疫苗 疫苗 疫苗一个辅助的辅助者.考古学是指古物质 (archaea) 是指古物质.考古物质是古物质的.葡萄糖类脂类化合物 葡萄糖类脂类化合物脂质体是一种脂质体.硫酸乳酸甲基甲基甲基甲基甲基甲基甲基甲基甲基甲基甲基甲基甲基更多相关视频
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
1.8K
06:02Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
Published on: February 23, 2024
603
相关概念视频
Outer Layers of the Cell Envelope
The outermost layers of prokaryotic cells play a critical role in their survival, virulence, and interaction with the environment. These layers, often composed of polysaccharides, polypeptides, or proteins, form protective and adhesive structures that vary in organization and function.Capsules and Slime LayersCapsules are highly organized, tightly bound layers that firmly attach to the bacterial cell wall. Capsules are usually made of polysaccharides, though some are made of polypeptides. These...
Surface Appendages of Archaea
Archaeal surface appendages are highly specialized structures essential for environmental adaptation, encompassing roles in adhesion, biofilm formation, and motility. Among these appendages, pili and archaella stand out for their distinct morphologies and functionalities, enabling archaea to thrive in diverse and often extreme environments.Pili: Adhesion and Biofilm FormationPili are filamentous structures assembled from pilin protein subunits, primarily contributing to adhesion and biofilm...
Formation of Lipopolysaccharides
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Viruses of Archaea
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
Archaeal Cell Wall
Archaeal cell walls are structurally and compositionally distinct from their bacterial counterparts, lacking the characteristic peptidoglycan layer found in most bacteria. Instead, archaeal cell walls exhibit remarkable diversity, utilizing materials such as pseudomurein, polysaccharides, and proteins to construct their protective outer layers. This structural flexibility is closely tied to archaea's ecological adaptability.S-Layers: The Common Archaeal Cell WallThe S-layer is the most...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
